Louis M. Staudt
Affiliations: | The George Washington University, Washington, DC, United States | ||
| 1988- | National Cancer Institute, Rockville, MD, United States |
Area:
Oncology, Cell BiologyWebsite:
https://ccr.cancer.gov/Lymphoid-Malignancies-Branch/louis-m-staudtGoogle:
"Louis Michael Staudt" OR "Louis M Staudt"Bio:
https://books.google.com/books?id=ANsRGt8_XWEC&lpg=PA170&pg=PA170#v=onepage&q&f=false
https://scholar.google.com/citations?user=rudQuL8AAAAJ&hl=en
Parents
Sign in to add mentor| Walter Gerhard | grad student | 1982 | Penn | |
| (The generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin : a dissertation in immunology) | ||||
| David Baltimore | post-doc | 1988 | Whitehead Institute | |
Children
Sign in to add trainee| Yunsheng He | grad student | 2001 | The George Washington University |
| N. C. Tolga Emre | post-doc | 2006-2010 | National Cancer Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Scheich S, Chen J, Liu J, et al. (2023) Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas. Cancer Discovery |
| Ishio T, Kumar S, Shimono J, et al. (2021) Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in Adult T-cell leukemia/lymphoma. Blood |
| Pighi C, Cheong TC, Compagno M, et al. (2021) Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma. Blood Advances. 5: 5239-5257 |
| Chiodin G, Allen JD, Bryant D, et al. (2021) Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior. Blood |
| Ruiz Cuevas MV, Hardy MP, Hollý J, et al. (2021) Most non-canonical proteins uniquely populate the proteome or immunopeptidome. Cell Reports. 34: 108815 |
| Wilke AC, Doebele C, Zindel A, et al. (2020) SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood |
| Dersh D, Phelan JD, Gumina ME, et al. (2020) Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas. Immunity |
| Fish K, Comoglio F, Shaffer AL, et al. (2020) Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A. Proceedings of the National Academy of Sciences of the United States of America |
| Pittaluga S, Nicolae A, Wright GW, et al. (2020) Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma. Blood Cancer Discovery. 1: 155-161 |
| Venturutti L, Teater M, Zhai A, et al. (2020) TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate. Cell |